BioProtocol (BIO) fluctuates 42.5% in 24 hours: EliLilly acquisition news and whale purchases drive rebound
Bitget Pulse2026/04/30 07:46Volatility Overview
In the past 24 hours, the price of BIO rebounded from a low of $0.03204 to a high of $0.04565, with the current quote at $0.0455, marking an overall amplitude of 42.5%. The 24-hour trading volume surged significantly to approximately $179 million, a sharp increase from usual levels, indicating heightened capital activity.
Brief Analysis of Market Movements
- Eli Lilly's acquisition of Crossbridge Bio (a VitaDAO derivative project) triggered BIO to become one of the day's hot coins, driving a price rebound and pushing it to the top of the trending list.
- A whale opened a $602k long position on Hyperliquid, combined with the upcoming Peptide TGE (Token Generation Event) and a staking priority mechanism, stimulating short-term buying interest.
- Technically, the price broke above the 8-hour descending wedge upper boundary, accompanied by increased trading volume, forming a series of higher highs.
Market Views and Outlook
The mainstream sentiment within the community is bullish, with several traders considering it “this week’s free long opportunity,” predicting further movement toward $0.0435-$0.056, but emphasize not to chase highs and to wait for pullbacks to enter, while warning against potential FOMO traps in the evening. Analysts point out the rebound potential at $0.045, but note that attention should be paid to the sustainability of the DeSci sector's valuation.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
When France and Germany pay for their deficits, fiscal discipline becomes the "moat" of the UK bond market; investors are positioning in advance for a rebound in gilt bonds.
Investors are betting that the new UK Chancellor, Healey, will uphold fiscal discipline and are purchasing gilts in advance. A smooth and steady budget plan is expected to turn the UK from a "risk" in the bond market into a "positive."
Anthropic's $2 Trillion IPO Faces Doubts: Risks of Mismatched Computing Commitments and Revenue
The independent institution New Constructs reported that the Anthropic IPO is absurd, with a valuation of only 150 billion. The main controversy lies in the mismatch between long-term computing power commitments and clients' short-term on-demand procurement models, coupled with macroeconomic headwinds and early investor sell-off pressure, leading to increased market volatility.
Anthropic allocates 5% of shares to set up a fund before IPO, Musk calls for direct distribution to the public
Anthropic announced the establishment of a public welfare fund, initially allocating 5% of its shares. When the company's valuation increases by 50%, another 2% will be added. The aim is to address the impact of AI on employment. Musk suggested directly distributing shares to the public.
AI Stocks Struggle to Rebound: Lacking Three Major Supports, July’s Rally Hard to Replicate
JPMorgan pointed out that due to the absence of ETF bargain-hunting funds, limited room for short covering, and the early termination of the $40 billion buyback by Samsung and SK Hynix, the rebound strength of AI stocks in October may not match that of July. The resurgence of leverage risk could intensify volatility.
Crypto prices
More
